|
LIN52 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.34699995602006E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.37179975448987E-10 |
| Normal-vs-Stage2 |
6.38099995065033E-09 |
| Normal-vs-Stage3 |
5.03849995059369E-09 |
| Normal-vs-Stage4 |
4.46920001007101E-09 |
| Stage1-vs-Stage2 |
3.668600E-01 |
| Stage1-vs-Stage3 |
2.721800E-01 |
| Stage1-vs-Stage4 |
9.625000E-01 |
| Stage2-vs-Stage3 |
9.577000E-01 |
| Stage2-vs-Stage4 |
5.070600E-01 |
| Stage3-vs-Stage4 |
4.886800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.86279946602053E-10 |
| Normal-vs-AfricanAmerican |
1.72650005403341E-09 |
| Normal-vs-Asian |
2.455800E-03 |
| Caucasian-vs-AfricanAmerican |
5.185200E-01 |
| Caucasian-vs-Asian |
6.160000E-01 |
| AfricanAmerican-vs-Asian |
7.859200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.83979983762129E-10 |
| Normal-vs-Female |
8.67700000739546E-09 |
| Male-vs-Female |
9.359700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.27720011922872E-10 |
| Normal-vs-Extreme_Weight |
2.09680051099781E-10 |
| Normal-vs-Obese |
2.25240004425586E-09 |
| Normal-vs-Extreme_Obese |
8.55030000135315E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.579390E-01 |
| Normal_Weight-vs-Obese |
5.269000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.488000E-01 |
| Extreme_Weight-vs-Obese |
2.050100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.588200E-01 |
| Obese-vs-Extreme_Obese |
4.907400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.37889999710595E-08 |
| Normal-vs-Age(41-60Yrs) |
1.12940001795181E-09 |
| Normal-vs-Age(61-80Yrs) |
1.28319999070925E-09 |
| Normal-vs-Age(81-100Yrs) |
9.06320019034013E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.369600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.812600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.847000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.872000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.990200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.836400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.33170055380572E-10 |
| Normal-VS-Type2 PRCC |
8.66740001992383E-09 |
| Normal-VS-KIRP CIMP |
5.578600E-04 |
| Normal-VS-Unclassified PRCC |
2.29810004359621E-09 |
| Type1 PRCC-VS-Type2 PRCC |
3.404800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.557390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.251500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.999000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.325400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.188600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.646000251185E-10 |
| Normal-vs-N1 |
4.43309999820229E-08 |
| Normal-vs-N2 |
2.162800E-03 |
| N0-vs-N1 |
9.505900E-02 |
| N0-vs-N2 |
4.312800E-01 |
| N1-vs-N2 |
1.779780E-01 |
|
|
